A peptoid inhibitor of Tat/TAR interaction with antiviral activity

Dirk Daelemans; Myriam Witvrouw; Christophe Pannecouque; De Clercq Erik; Anne‐Mieke Vandamme

Related publications

Article2013

Design, Synthesis and Biological Evaluation of Substituted Guanidine Indole Derivatives as Potential Inhibitors of HIV-1 Tat-TAR Interaction

Jun Wang, Yan Wang, Zhenyu Li, Peng Zhan, Ru-Jun Bai, Christophe Pannecouque, Jan Balzarini, De Clercq Erik, Xinyong Liu

Article2011

Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses

Emanuel Haasbach, Eva-Katharina Pauli, Robert Spranger, David Mitzner, Ulrich Sigmar Schubert, Ralf Kircheis, Oliver Planz

Article2003

Discovery of a Tat HIV‐1 Inhibitor through Computer‐Aided Drug Design

Didier Esquieu, Jean‐Marie Péloponèse, Sandrine Opi, Catherine Grégoire, Jean de Mareuil, Jennifer Watkins, Grant R. Campbell, Jean-Pierre Dunot, James N. Sturgis, Myriam Witvrouw, Christophe Pannecouque, De Clercq Erik, Mickaël Montembault, Giang Vo‐Thanh, Monique Villiéras, Valérie Fargeas, Jacques Lebreton, Erwann Loret

Article2020

Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity

Tina Bagratuni, Dimitrios Patseas, Nefeli Mavrianou‐Koutsoukou, Christine‐Ivy Liacos, Aimilia D. Sklirou, Pantelis Rousakis, Maria Gavriatopoulou, Evangelos Terpos, Ourania Tsitsilonis, Ioannis P. Trougakos, Efstathios Kastritis, Meletios A Dimopoulos

Article2015

Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity

Tina Bagratuni, Nefeli Mavrianou, Efstathios Kastritis, Christine Liakos, Evangelos Terpos, Meletios A Dimopoulos

A peptoid inhibitor of Tat/TAR interaction with antiviral activity

Discussion(0)

Related publications

Design, Synthesis and Biological Evaluation of Substituted Guanidine Indole Derivatives as Potential Inhibitors of HIV-1 Tat-TAR Interaction

Antiviral activity of the proteasome inhibitor VL-01 against influenza A viruses

Discovery of a Tat HIV‐1 Inhibitor through Computer‐Aided Drug Design

Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity

Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity